116 related articles for article (PubMed ID: 1083976)
1. [Effect of combined immunosuppressive treatment with Imuran and prednisone on the concentration of selected immune proteins in the serum of patients with lupus erythematosus].
Chwal Z
Pol Tyg Lek; 1976 May; 31(16):659-61. PubMed ID: 1083976
[No Abstract] [Full Text] [Related]
2. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
[No Abstract] [Full Text] [Related]
3. [Effect of immunosuppressive therapy with nitrogen mustard on serum concentration of immunoglobulins, C-3 component of complement and alpha-1-antitrypsin in patients with rheumatoid arthritis].
Chwal Z
Pol Tyg Lek; 1976 Apr; 31(14):561-3. PubMed ID: 1083974
[No Abstract] [Full Text] [Related]
4. [Immunosuppressive therapy of systemic lupus erythematosus].
Miescher PA; Lambert PH
Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
[No Abstract] [Full Text] [Related]
5. [Clinical observations on C3 and CH50 in the serum of patients with systemic lupus erythematosus].
Jin A
Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):36-8. PubMed ID: 6430492
[No Abstract] [Full Text] [Related]
6. [Effect of immunosuppressive agents on the humoral immunity].
Chwal Z
Pol Tyg Lek; 1976 Apr; 31(15):605-7. PubMed ID: 1083975
[No Abstract] [Full Text] [Related]
7. Significance of in vivo-bound immunoglobulins and complement in the skin of systemic lupus erythematosus patients.
Deng JS; Lin RY; Lu YC
J Dermatol; 1976 Oct; 3(5):237-40. PubMed ID: 798742
[No Abstract] [Full Text] [Related]
8. [Observation of the third component of complement (C3) and total hemolytic complement (CH50) in serum with SLE].
Jin A; Chen P; Ke X; Yu M; Fan L; Zhang N; Hou J; Ling Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):322-3. PubMed ID: 6219771
[No Abstract] [Full Text] [Related]
9. Immunoglobulins in the larynx in systemic lupus erythematosus.
Gilliam JN; Cheatum DE
Arch Dermatol; 1973 Nov; 108(5):696-7. PubMed ID: 4127210
[No Abstract] [Full Text] [Related]
10. [Acute polyvisceral lupus erythematosus in a young 12-year-old girl. The value of plasma exchange].
Palcoux JB; de Champs C; Roche M; Vanlieferinghen P
Pediatrie; 1983 Mar; 38(2):119-23. PubMed ID: 6622140
[TBL] [Abstract][Full Text] [Related]
11. [Study of B-lymphocytes with receptors to C3 component of complement in patients with glomerulonephritis and systemic lupus erythematosus].
Gordovskaia NB; Bulanova TD; Traianova TG
Ter Arkh; 1977; 49(7):45-50. PubMed ID: 331546
[No Abstract] [Full Text] [Related]
12. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
13. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
Clément F
Schweiz Med Wochenschr; 1973 Oct; 103(40):1369-77. PubMed ID: 4755631
[No Abstract] [Full Text] [Related]
14. [The significance of serum concentration of C3 and C4 for the diagnosis, prognosis and treatment of SLE].
Yasue T; Akutsu J; Shinjô H; Sasada K
Nihon Hifuka Gakkai Zasshi; 1975 Dec; 85(14):875-83. PubMed ID: 1240511
[No Abstract] [Full Text] [Related]
15. [Changes in the cellular-humoral immune reactivity of patients with lupus nephritis and chronic glomerulonephritis treated with corticosteroids or corticosteroids and imuran].
Stefanova G; Mikhaĭlova A; Gavrilov G; Naumova E; Bŭchvarova E
Vutr Boles; 1983; 22(5):65-71. PubMed ID: 6673336
[TBL] [Abstract][Full Text] [Related]
16. [Immunosuppressive long term therapy of visceral lupus erythematosus].
Schubert JC; Schubert H; Holtz G; Martin H
Dtsch Med Wochenschr; 1970 Aug; 95(35):1768-74. PubMed ID: 4195000
[No Abstract] [Full Text] [Related]
17. The terminal complement complex, C5b-9, a marker of disease activity in patients with systemic lupus erythematosus.
Gawryl MS; Chudwin DS; Langlois PF; Lint TF
Arthritis Rheum; 1988 Feb; 31(2):188-95. PubMed ID: 3348822
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive drugs plus prednisone versus prednisone alone in lupus nephritis.
N Engl J Med; 1985 Apr; 312(14):921-2. PubMed ID: 3974677
[No Abstract] [Full Text] [Related]
19. Transition from systemic lupus erythematosus to common variable hypogammaglobulinemia.
Sussman GL; Rivera VJ; Kohler PF
Ann Intern Med; 1983 Jul; 99(1):32-5. PubMed ID: 6859720
[TBL] [Abstract][Full Text] [Related]
20. [Immunopathological manifestations of systemic lupus erythematosus and their correction during long-term dispensary observation].
Matveĭkov GP; Titova IP; Kaliia ES; Dosin IuM
Ter Arkh; 1987; 59(5):27-31. PubMed ID: 3497464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
